Skip to content

Risk Factors for Community- and Workplace Transmission of COVID-19

Risk Factors for Community- and Workplace Transmission of COVID-19

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04320732
Enrollment
250000
Registered
2020-03-25
Start date
2020-03-27
Completion date
2030-03-20
Last updated
2021-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronavirus

Brief summary

The project is an epidemiological observational study based on an electronic questionnaire on risk factors for COVID-19 in the community and healthcare setting.

Detailed description

Summary The data collected will identify real-life risk factors for getting the COVID-19 diagnosis. The Oslo University Hospital/University of Oslo web-based solution nettskjema will be used to collect data and consent forms. The impact of knowing the risk factors for COVID-19 is tremendous because it can enable governments to conduct more targeted public health measurements than today to reduce the spread of the virus. Detailed description Research into an ongoing COVID-19 outbreak is difficult because patients are isolated, and supplies of personal protective equipment (PPE) supplies are limited. The risk of transmission to study personal is non-negligible even when PPE is available. A study design based on an electronic questionnaire and consent from delivered from the Oslo University Hospital/University of Oslo, GDPR (General Data Protection Regulation) compliant TSD service has therefore been chosen. The study will be a case-control study based on a combined electronic consent form and questionnaire that the participants will fill in using a smartphone and electronic identification. The groups that will be included are: * Hospitalized and non-hospitalized patients/persons with COVID-19 at all stages of the disease and after the disease * Hospitalized patients without COVID-19 * Healthcare personal or other groups with an increased risk of COVID-19 * Healthy volunteers Participants may be followed with repeated questionnaires prospectively. Biological samples Biological samples may hold crucial information about the susceptibility to COVID-19 and for susceptibility to the progression of the disease. It is within the scope of the study to analyze such samples from a limited number of participants which will be asked to provide such samples or hospitalized patients that have surplus material. The material will be analyzed with non-genetic methods most suitable to provide such information.

Interventions

BEHAVIORALObservation of behavior and COVID-19 infection will be conducted.

No intervention, only prospective observation of behavior will be conducted by a questionnaire.

Sponsors

Age Labs AS
CollaboratorUNKNOWN
Oslo University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Norwegian adult

Exclusion criteria

* Unable to consent

Design outcomes

Primary

MeasureTime frameDescription
Rate of COVID-19 infection1 yearDiagnosed with serology or direct viral detection

Countries

Norway

Contacts

Primary ContactArne Søraas, MD, PhD
Arne.Vasli.Lund.Soraas@rr-research.no+4790652904
Backup ContactJohn Arne Dahl, PhD
j.a.dahl@medisin.uio.no

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026